Skip Navigation


eBAT and Its Potential as a New Treatment for Hemangiosarcoma

  • eBAT is a new type of drug designed to attack specific molecules present exclusively or at high levels in tumors.
  • eBAT is still an experimental drug, but it has been shown to be safe and appears to have potential to improve the treatment outcome for dogs with hemangiosarcoma when added to the standard of care (surgery + chemotherapy).
  • Ongoing research will allow us to determine whether eBAT might also benefit dogs and people with other incurable cancers.

To read more about eBAT, click here.